Literature DB >> 1332696

Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.

J T O'Flaherty1, D P Jacobson, J F Redman.   

Abstract

Platelet-activating factor (PAF) desensitizes as well as stimulates its various target cells, We find that human polymorphonuclear neutrophils (PMN) exposed to PAF became maximally unresponsive to a second PAF challenge within 15-90 s in assays of Ca2+ mobilization and degranulation. The cells regained full PAF-sensitivity over the ensuing 20-40 min. These effects correlated with changes in PAF receptor availability. PMN treated with PAF, washed in regular buffer and assayed for PAF binding exhibited falls (maximal in 15 s), followed by rises (reaching control levels by 60 min), in the number of high-affinity PAF receptors. However, tracking studies showed that [3H]PAF accumulated on the cell surface for approximately 2 min before being internalized. Regular-buffer washes did not remove this superficial PAF, whereas a washing regimen using excess albumin to adsorb PAF removed 99% of the surface compound. PMN washed by the latter regimen after PAF exposure lost PAF receptors relatively slowly (maximal at approximately 5 min), but the ultimate extent of this loss and the rate at which receptor expression normalized were similar to those of cells washed in regular buffer. Neither cycloheximide nor actinomycin D influenced the course of the receptor changes, but two protein kinase C (PKC) blockers, staurosporine and 1-(5-isoquinolinesulphonyl)piperazine, inhibited the receptor-receptor-depleting actions of PAF. Indeed, a phorbol diester activator of PKC also caused PMN to decrease high-affinity PAF receptor numbers, and the two PKC blockers antagonized this action at concentrations that inhibited PAF-induced PAF receptor losses. We conclude that: (a) PAF induces PMN to down-regulate and then to re-express PAF receptors independently of protein synthesis; (b) these changes are likely to underlie the later stages and reversal of desensitization; (c) the onset (t < or = 2 min) of desensitization, however, precedes receptor down-regulation and must be due to receptor uncoupling from transductional elements; and (d) down-regulation of receptors for PAF appears to be mediated by PKC and/or elements inhibited by PKC blockers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332696      PMCID: PMC1132104          DOI: 10.1042/bj2880241

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Regulation of platelet-activating factor receptors in rat Kupffer cells.

Authors:  W Chao; H Liu; D J Hanahan; M S Olson
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

Review 2.  Platelet-activating factor.

Authors:  S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

3.  Effects of H-7 are not exclusively mediated through protein kinase C or the cyclic nucleotide-dependent kinases.

Authors:  J T Love; S J Padula; E G Lingenheld; J K Amin; D C Sgroi; R L Wong; R I Sha'fi; R B Clark
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

Review 4.  Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids.

Authors:  F Snyder
Journal:  Proc Soc Exp Biol Med       Date:  1989-02

5.  Treatment of intact hepatocytes with either the phorbol ester TPA or glucagon elicits the phosphorylation and functional inactivation of the inhibitory guanine nucleotide regulatory protein Gi.

Authors:  N J Pyne; G J Murphy; G Milligan; M D Houslay
Journal:  FEBS Lett       Date:  1989-01-16       Impact factor: 4.124

6.  Stimulation and priming of protein kinase C translocation by a Ca2+ transient-independent mechanism. Studies in human neutrophils challenged with platelet-activating factor and other receptor agonists.

Authors:  J T O'Flaherty; J F Redman; D P Jacobson; A G Rossi
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

7.  Regulation of platelet-activating factor receptor and PAF receptor-mediated arachidonic acid release by protein kinase C activation in rat Kupffer cells.

Authors:  W Chao; H Liu; D J Hanahan; M S Olson
Journal:  Arch Biochem Biophys       Date:  1990-10       Impact factor: 4.013

8.  Receptor-independent metabolism of platelet-activating factor by myelogenous cells.

Authors:  J T O'Flaherty; M C Chabot; J Redman; D Jacobson; R L Wykle
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

9.  Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics.

Authors:  H Homma; D J Hanahan
Journal:  Arch Biochem Biophys       Date:  1988-04       Impact factor: 4.013

10.  Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells.

Authors:  T Sako; A I Tauber; A Y Jeng; S H Yuspa; P M Blumberg
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

View more
  3 in total

Review 1.  Platelet-activating factor antagonists.

Authors:  M Koltai; P G Braquet
Journal:  Clin Rev Allergy       Date:  1994

2.  Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor.

Authors:  H Wang; X Tan; H Chang; F Gonzalez-Crussi; D G Remick; W Hsueh
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

3.  Tumor necrosis factor-alpha causes release of cytosolic interleukin-18 from human neutrophils.

Authors:  Christopher C Silliman; Marguerite R Kelher; Fabia Gamboni-Robertson; Christine Hamiel; Kelly M England; Charles A Dinarello; Travis H Wyman; Samina Y Khan; Nathan J D McLaughlin; Rachel S Bercovitz; Anirban Banerjee
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-11       Impact factor: 4.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.